Evidence supporting the use of: Schisandrin
For the health condition: Chronic Obstructive Pulmonary Disorder

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Schisandrin, a lignan compound derived from the fruit of Schisandra chinensis, has a history of use in traditional Chinese medicine, primarily for enhancing vitality and supporting liver function. In recent years, emerging scientific studies have investigated its potential for respiratory health, including its effects on Chronic Obstructive Pulmonary Disease (COPD). Preclinical evidence suggests that Schisandrin possesses anti-inflammatory, antioxidant, and anti-fibrotic properties, which could theoretically benefit COPD, a condition characterized by chronic inflammation and oxidative stress in the airways.

Several animal studies have demonstrated that Schisandrin and related lignans can attenuate lung inflammation and reduce oxidative damage in models of COPD or cigarette smoke-induced lung injury. For example, a study published in the journal Phytomedicine (2015) found that Schisandrin B reduced inflammatory cytokine levels in a mouse model of COPD. However, these findings are limited to preclinical research; there is currently a lack of robust human clinical trials evaluating Schisandrin’s efficacy or safety for COPD management.

In summary, while there is some scientific rationale and promising preclinical data supporting Schisandrin’s potential role in mitigating COPD-related inflammation and oxidative stress, the evidence is still preliminary. Clinical validation in humans is lacking, so the current rating for scientific evidence is low to moderate (2/5).

More about Schisandrin
More about Chronic Obstructive Pulmonary Disorder

Products containing Schisandrin

We currently have no products on Vitabase that contain this ingredient.